Alnylam Pharmaceuticals Inc Cash Flow Reinvestment Rate
Alnylam Pharmaceuticals Inc cash flow reinvestment rate. Alnylam Pharmaceuticals Inc (ALNY) has a Cash Flow Reinvestment Rate of 0.23x as of December 2025, reinvesting $37.17 Million (capex $23.29 Million plus investments $-13.87 Million) from operating cash flow of $163.56 Million. See ALNY free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Alnylam Pharmaceuticals Inc (2007–2025)
Cash flow reinvestment rate of Alnylam Pharmaceuticals Inc from 2007 to 2025. Historical reinvestment intensity for Alnylam Pharmaceuticals Inc across 4 annual periods. Explore ALNY operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Alnylam Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2007–2025)
Alnylam Pharmaceuticals Inc cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Alnylam Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Alnylam Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.06x | $555.87 Million | $524.08 Million | $58.70 Million | ▼ -62.9% |
| 2023 | 2.86x | $297.82 Million | $104.16 Million | $62.21 Million | ▲ +1639.7% |
| 2008 | 0.16x | $10.76 Million | $65.49 Million | $10.76 Million | ▲ +314.7% |
| 2007 | 0.04x | $7.79 Million | $196.52 Million | $7.79 Million | — |